These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 22791547

  • 1. Methylphenidate-induced acute orofacial and extremity dyskinesia.
    Yilmaz AE, Donmez A, Orun E, Tas T, Isik B, Sonmez FM.
    J Child Neurol; 2013 Jun; 28(6):781-3. PubMed ID: 22791547
    [Abstract] [Full Text] [Related]

  • 2. Adverse response to methylphenidate in combination with valproic acid.
    Gara L, Roberts W.
    J Child Adolesc Psychopharmacol; 2000 Jun; 10(1):39-43. PubMed ID: 10755581
    [Abstract] [Full Text] [Related]

  • 3. Methylphenidate-induced orofacial and extremity dyskinesia.
    Balázs J, Besnyo M, Gádoros J.
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):378-81. PubMed ID: 17630872
    [Abstract] [Full Text] [Related]

  • 4. Isolated orofacial dyskinesia: a methylphenidate-induced movement disorder.
    Senecky Y, Lobel D, Diamond GW, Weitz R, Inbar D.
    Pediatr Neurol; 2002 Sep; 27(3):224-6. PubMed ID: 12393134
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.
    Kummer A, Teixeira A.
    Australas Psychiatry; 2008 Dec; 16(6):458-9. PubMed ID: 19034996
    [No Abstract] [Full Text] [Related]

  • 8. Methylphenidate treatment and dyskinesia in children with attention-deficit/hyperactivity disorder.
    Balázs J, Dallos G, Keresztény A, Czobor P, Gádoros J.
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):133-8. PubMed ID: 21486166
    [Abstract] [Full Text] [Related]

  • 9. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C, Boidein F.
    Encephale; 2001 Apr; 27(5):435-43. PubMed ID: 11760693
    [Abstract] [Full Text] [Related]

  • 10. Risperidone-to-methylphenidate switch reaction in children: three cases.
    Sabuncuoglu O.
    J Psychopharmacol; 2007 Mar; 21(2):216-9. PubMed ID: 17329303
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P, Sever J, Weizman A.
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [Abstract] [Full Text] [Related]

  • 12. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
    Lewis H, Lewis J.
    Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
    Moungnoi P, Maipang P.
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature.
    Kraemer M, Uekermann J, Wiltfang J, Kis B.
    Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380
    [Abstract] [Full Text] [Related]

  • 20. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.